THC impairs short-term memory through a specific protein signaling pathway in the hippocampus

Mice were tested on a novel object recognition memory paradigm. THC was administered systemically, and PKC inhibitors or mTOR inhibitors were given either systemically or directly into the hippocampus via microinjection. Immunoblot analysis measured PKC phosphorylation, PKC isoform expression, and neurogranin phosphorylation in hippocampal tissue.

Understanding the specific molecular mechanism behind THC's memory-impairing effects opens the door to developing interventions that could prevent cognitive side effects while preserving therapeutic benefits. The discovery that short-term and long-term memory impairment use different pathways suggests that targeted approaches could potentially block one without affecting the other.

This study adds molecular precision to our understanding of cannabis-related cognitive impairment. Rather than viewing THC's memory effects as a single phenomenon, this work shows they involve distinct signaling cascades that could potentially be targeted independently, moving toward cannabis-based medicines that work without impairing memory.

This is a mouse study, and the specific PKC pathways may function differently in human hippocampal neurons. The novel object recognition task captures only one dimension of memory. PKC inhibitors used are research tools, not clinical drugs. The study used acute THC exposure and results may differ with chronic use.